MONQ Personal Aromatherapy Diffuser Safety

What are MONQ Personal Aromatherapy Diffusers?

MONQ personal aromatherapy diffusers are innovative essential oil delivery devices without the harmful effects and additives found in e-cigarettes. Each device is filled with a specially crafted, synergistic essential oil blend derived from pure, organic essential oils.

How to Use MONQ Personal Aromatherapy Diffusers

MONQ personal aromatherapy diffusers are used by breathing in the essential oil blend orally as if sucking liquid through a straw, and slowly exhaling the vapor through the nose. Inhalation to the lungs is not recommended and will lead to a wasted product. Generally, MONQ recommends using MONQ personal aromatherapy diffusers not more than 3-puffs, 3-times per day. Following this regimen, adverse symptoms are likely to be avoided.

Safety Profile: MONQ Personal Aromatherapy Diffusers

  • Rarely, mucosal irritation and dryness in the nose or back of the throat may occur. Extreme use may lead to dried and cracked mucous membranes with subsequent bleeding (Liu et al., 2018). Because MONQ uses vegetable glycerin (as opposed to propylene glycol) heated to a temperature that is 100 degrees Fahrenheit below the temperature required to form formaldehyde, the risk of nasal irritation is diminished compared to that of many e-cigarette devices or personal diffusers.
  • Anosmia, a loss in olfaction (sense of smell) has not been linked to the use of MONQ personal aromatherapy diffusers but has been linked to e-cigarette use (Ajmani, Suh, Wroblewski, & Pinto, 2017). MONQ personal aromatherapy diffusers may heighten the perception of odors and olfactory acuity by activating sensory receptors for olfaction and exercising olfactory pathways. Activation of these olfactory receptors may improve wakefulness and diminish fatigue (Saito et al., 2018).
  • Infection is unlikely to result from using MONQ personal aromatherapy diffusers. MONQ recommends storing MONQ personal aromatherapy diffusers in a clean place free of debris to prevent contamination of the oral tip. Further, MONQ recommends individuals avoid sharing personal aromatherapy diffusers to decrease the potential of spreading bacteria and viruses. MONQ personal aromatherapy diffusers are not e-cigarettes and do not contain harmful carriers and secondary substances such as nicotine, propylene glycol, and formaldehyde, which may increase the risk of infection. In high doses (averaging 200-puffs/day) e-cigarettes have been linked to immune system suppression. (Martin et al., 2016). However, MONQ recommends no more than 9-puffs/day and does not use harmful carriers.
  • MONQ personal aromatherapy diffusers do not cause lung injury. Lung inhalation is neither required nor recommended. Additionally, by keeping lower temperatures, avoiding propylene glycol and its secondary metabolite, formaldehyde, and by limiting use to 9-puffs/day, the harmful effects linked to e-cigarette use may be avoided. Bronchoscopic biopsies of lung tissue in e-cigarette users have been found to contain changes in protein expression (Ghosh et al., 2018). MONQ has formulated personal aromatherapy diffusers to avoid these potential risks.

MONQ personal aromatherapy diffusers are SAFE.

Breathe the air you evolved to breathe.


Ajmani, G. S., Suh, H. H., Wroblewski, K. E., & Pinto, J. M. (2017). Smoking and olfactory dysfunction: A systematic literature review and meta-analysis. Laryngoscope, 127(8), 1753–1761.

Ghosh, A., Coakley, R. C., Mascenik, T., Rowell, T. R., Davis, E. S., Rogers, K., … Tarran, R. (2018). Chronic e-cigarette exposure alters the human bronchial epithelial proteome. American Journal of Respiratory and Critical Care Medicine, 198(1), 67–76.

Liu, X., Lu, W., Liao, S., Deng, Z., Zhang, Z., Liu, Y., & Lu, W. (2018). Efficiency and adverse events of electronic cigarettes: A systematic review and meta-analysis (PRISMA-compliant article). Medicine, 97(19), e0324.

Martin, E. M., Clapp, P. W., Rebuli, M. E., Pawlak, E. A., Glista-Baker, E., Benowitz, N. L., … Jaspers, I. (2016). e-cigarette use results in suppression of immune and inflammatory response genes in nasal epithelial cells similar to cigarette smoke. American Journal of Physiology-Lung Cellular and Molecular Physiology, 311(1), L135–L144.

Saito, N., Yamano, E., Ishii, A., Tanaka, M., Nakamura, J., & Watanabe, Y. (2018). Involvement of the olfactory system in the induction of anti-fatigue effects by odorants. PLoS ONE, 13(3).

Angelique Cohen, MD, MBA, is a physician advisor at Saint Thomas Health in Nashville, Tenn. Her clinical specialty is otolaryngology, head, and neck surgery. Dr. Cohen has successfully practiced medicine since 1996 and owned her own practice in Illinois before relocating to Nashville where she serves in a dual capacity.